Short Name | TargetExo-RVG (Personalization) |
Description | Exosome surface-modified targeting peptide RVG. nACHRA7 is the targeting receptor |
Technology Applications | Commonly used in the treatment of Alzheimer's disease, Parkinson's disease, glioma, and depression |
Storage | 2 °C to 8 °C |
Shelf-life | 2 years |
Structure |
Catalog: CDE23-001
Catalog: CDE23-002
Catalog: CDE23-003
Catalog: CDE23-004
Catalog: CDE23-005
Catalog: CDE23-006
Catalog: CDE23-007
Catalog: CDE23-008